The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease
Article first published online: 4 MAR 2013
© 2013 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 37, Issue 9, pages 905–914, May 2013
How to Cite
Emilsson, L., Carlsson, R., Holmqvist, M., James, S. and Ludvigsson, J. F. (2013), The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease. Alimentary Pharmacology & Therapeutics, 37: 905–914. doi: 10.1111/apt.12271
- Issue published online: 3 APR 2013
- Article first published online: 4 MAR 2013
- Manuscript Accepted: 11 FEB 2013
- Manuscript Revised: 30 JAN 2013
- Manuscript Revised: 15 JAN 2013
- Manuscript Received: 17 DEC 2012
Studies have shown an increased risk of ischaemic heart disease (IHD) in patients with coeliac disease (CD), despite the patients' lack of traditional IHD risk factors.
To characterise IHD according to CD status.
Data on duodenal or jejunal biopsies were collected in 2006–2008 from all 28 pathology departments in Sweden and were used to define CD (equal to villous atrophy; Marsh stage 3). We used the Swedish cardiac care register SWEDEHEART to identify IHD and to obtain data on clinical status and risk factors at time of first myocardial infarction for this case-only comparison. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). CD patients were compared with general population reference individuals.
We identified 1075 CD patients and 4142 reference individuals with subsequent IHD. CD patients with myocardial infarction had lower body mass index (P < 0.001) and cholesterol values (P < 0.001) and were less likely to be active smokers (OR = 0.74; 95% CI = 0.56–0.98) than reference individuals with myocardial infarction. CD patients had less extensive coronary artery disease at angiography (any stenosis: OR = 0.80; 95% CI = 0.66–0.97; three-vessel disease: OR = 0.73; 95% CI = 0.57–0.94); but there was no difference in the proportions of CD patients with positive biochemical markers of myocardial infarction (CD: 92.2% vs. reference individuals: 91.5%, P = 0.766).
Despite evidence of an increased risk of IHD and higher cardiovascular mortality, patients with coeliac disease with IHD have a more favourable cardiac risk profile compared with IHD in reference individuals.